|
1
|
Hausenloy DJ and Yellon DM: Myocardial
ischemia-reperfusion injury: A neglected therapeutic target. J Clin
Invest. 123:92–100. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chandrasekar B, Smith JB and Freeman GL:
Ischemia-reperfusion of rat myocardium activates nuclear
factor-KappaB and induces neutrophil infiltration via
lipopolysaccharide-induced CXC chemokine. Circulation.
103:2296–2302. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kaminski KA, Bonda TA, Korecki J and
Musial WJ: Oxidative stress and neutrophil activation-the two
keystones of ischemia/reperfusion injury. Int J Cardiol. 86:41–59.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Eefting F, Rensing B, Wigman J, Pannekoek
WJ, Liu WM, Cramer MJ, Lips DJ and Doevendans PA: Role of apoptosis
in reperfusion injury. Cardiovasc Res. 61:414–426. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kumar KG, Trevaskis JL, Lam DD, Sutton GM,
Koza RA, Chouljenko VN, Kousoulas KG, Rogers PM, Kesterson RA,
Thearle M, et al: Identification of adropin as a secreted factor
linking dietary macronutrient intake with energy homeostasis and
lipid metabolism. Cell Metab. 8:468–481. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lovren F, Pan Y, Quan A, Singh KK, Shukla
PC, Gupta M, Al-Omran M, Teoh H and Verma S: Adropin is a novel
regulator of endothelial function. Circulation 122 (11 Suppl).
S185–S192. 2010. View Article : Google Scholar
|
|
7
|
Butler AA, Tam CS, Stanhope KL, Wolfe BM,
Ali MR, O'Keeffe M, St-Onge MP, Ravussin E and Havel PJ: Low
circulating adropin concentrations with obesity and aging correlate
with risk factors for metabolic disease and increase after gastric
bypass surgery in humans. J Clin Endocrinol Metab. 97:3783–3791.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Celik A, Balin M, Kobat MA, Erdem K,
Baydas A, Bulut M, Altas Y and Aydin S and Aydin S: Deficiency of a
new protein associated with cardiac syndrome X; called adropin.
Cardiovasc Ther. 31:174–178. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu L, Fang J, Chen L, Zhao Z, Luo Y, Lin C
and Fan L: Low serum adropin is associated with coronary
atherosclerosis in type 2 diabetic and non-diabetic patients. Clin
Chem Lab Med. 52:751–758. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang C, DeMars KM, Hawkins KE and
Candelario-Jalil E: Adropin reduces paracellular permeability of
rat brain endothelial cells exposed to ischemia-like conditions.
Peptides. 81:29–37. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tanaka M, Ito H, Adachi S, Akimoto H,
Nishikawa T, Kasajima T, Marumo F and Hiroe M: Hypoxia induces
apoptosis with enhanced expression of Fas antigen messenger RNA in
cultured neonatal rat cardiomyocytes. Circ Res. 75:426–433. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Singla DK, Singla RD and McDonald DE:
Factors released from embryonic stem cells inhibit apoptosis in
H9c2 cells through PI3K/Akt but not ERK pathway. Am J Physiol Heart
Circ Physiol. 295:H907–H913. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ogata Y, Takahashi M, Ueno S, Takeuchi K,
Okada T, Mano H, Ookawara S, Ozawa K, Berk BC, Ikeda U, et al:
Antiapoptotic effect of endothelin-1 in rat cardiomyocytes in
vitro. Hypertension. 41:1156–1163. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Scarabelli TM, Knight R, Stephanou A,
Townsend P, Chen-Scarabelli C, Lawrence K, Gottlieb R, Latchman D
and Narula J: Clinical implications of apoptosis in ischemic
myocardium. Curr Probl Cardiol. 31:181–264. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pchejetski D, Kunduzova O, Dayon A, Calise
D, Seguelas MH, Leducq N, Seif I, Parini A and Cuvillier O:
Oxidative stress-dependent sphingosine kinase-1 inhibition mediates
monoamine oxidase A-associated cardiac cell apoptosis. Circ Res.
100:41–49. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fu J, Huang H, Liu J, Pi R, Chen J and Liu
P: Tanshinone IIA protects cardiac myocytes against oxidative
stress-triggered damage and apoptosis. Eur J Pharmacol.
568:213–221. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Song JQ, Teng X, Cai Y, Tang CS and Qi YF:
Activation of Akt/GSK-3beta signaling pathway is involved in
intermedin(1–53) protection against myocardial apoptosis induced by
ischemia/reperfusion. Apoptosis. 14:1299–1307. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Frangogiannis NG, Smith CW and Entman ML:
The inflammatory response in myocardial infarction. Cardiovasc Res.
53:31–47. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Marx N, Neumann FJ, Ott I, Gawaz M, Koch
W, Pinkau T and Schömig A: Induction of cytokine expression in
leukocytes in acute myocardial infarction. J Am Coll Cardiol.
30:165–170. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kumar D and Jugdutt BI: Apoptosis and
oxidants in the heart. J Lab Clin Med. 142:288–297. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kumar D, Lou H and Singal PK: Oxidative
stress and apoptosis in heart dysfunction. Herz. 27:662–668. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhao ZQ: Oxidative stress-elicited
myocardial apoptosis during reperfusion. Curr Opin Pharmacol.
4:159–165. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liang R, Zhao Q, Jian G, Cheng D, Wang N,
Zhang G and Wang F: Tanshinone IIA attenuates contrast-induced
nephropathy via Nrf2 activation in rats. Cell Physiol Biochem.
46:2616–2623. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kong Y, Yin J, Cheng D, Lu Z, Wang N, Wang
F and Liang M: Antithrombin III attenuates AKI following acute
severe pancreatitis. Shock. 49:572–579. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yellon DM and Hausenloy DJ: Myocardial
reperfusion injury. N Engl J Med. 357:1121–1135. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ovize M, Baxter GF, Di Lisa F, Ferdinandy
P, Garcia-Dorado D, Hausenloy DJ, Heusch G, Vinten-Johansen J,
Yellon DM and Schulz R; Working Group of Cellular Biology of Heart
of European Society of Cardiology, : Postconditioning and
protection from reperfusion injury: Where do we stand? Position
paper from the working group of cellular biology of the heart of
the European Society of Cardiology. Cardiovasc Res. 87:406–423.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hausenloy DJ and Yellon DM: New directions
for protecting the heart against ischaemia-reperfusion injury:
Targeting the reperfusion injury salvage kinase (RISK)-pathway.
Cardiovasc Res. 61:448–460. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhu M, Feng J, Lucchinetti E, Fischer G,
Xu L, Pedrazzini T, Schaub MC and Zaugg M: Ischemic
postconditioning protects remodeled myocardium via the PI3K-PKB/Akt
reperfusion injury salvage kinase pathway. Cardiovasc Res.
72:152–162. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Armstrong SC: Protein kinase activation
and myocardial ischemia/reperfusion injury. Cardiovasc Res.
61:427–436. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mullonkal CJ and Toledo-Pereyra LH: Akt in
ischemia and reperfusion. J Invest Surg. 20:195–203. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jeong JJ, Ha YM, Jin YC, Lee EJ, Kim JS,
Kim HJ, Seo HG, Lee JH, Kang SS, Kim YS and Chang KC: Rutin from
Lonicera japonica inhibits myocardial ischemia/reperfusion-induced
apoptosis in vivo and protects H9c2 cells against hydrogen
peroxide-mediated injury via ERK1/2 and PI3K/Akt signals in vitro.
Food Chem Toxicol. 47:1569–1576. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lacerda L, Somers S, Opie LH and Lecour S:
Ischaemic postconditioning protects against reperfusion injury via
the SAFE pathway. Cardiovasc Res. 84:201–208. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lecour S: Activation of the protective
survivor activating factor enhancement (SAFE) pathway against
reperfusion injury: Does it go beyond the RISK pathway? J Mol Cell
Cardiol. 47:32–40. 2009. View Article : Google Scholar : PubMed/NCBI
|
